Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator- Initiated Studies (UH3 Clincical Trial Not Allowed)

forecasted

Through this Notice of Funding Opportunity, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for continuing research on advancing the field of regenerative medicine using adult stem cells and will take advantage of remaining funds authorized through the 21st Century Cures Act for this initiative. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the UH3 activity code. Investigators who have been previously funded through the Regenerative Medicine Innovation Project are encouraged to begin to consider applying for this new NOFO.